StockData
Protagenic Therapeutics, Inc.new logo

Protagenic Therapeutics, Inc.new (PTIX) stock

PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.36MP/E –Yield –

Protagenic Therapeutics, Inc.new total assets

Total assets on the balance sheet at the end of each period.

Protagenic Therapeutics, Inc.new's total assets was $2.80M at Jun 30, 2026. For fiscal 2024 it was $1.96M, down 54.8% from the year before. The highest annual figure on record is $11.06M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2024Dec 31, 2024$1.96M-54.8%
FY2023Dec 31, 2023$4.32M-46.2%
FY2022Dec 31, 2022$8.04M-27.3%
FY2021Dec 31, 2021$11.06M+1157.9%
FY2020Dec 31, 2020$879.25K+4.4%
FY2019Dec 31, 2019$842.27K+20.9%
FY2018Dec 31, 2018$696.88K-60.9%
FY2017Dec 31, 2017$1.78M-43.7%
FY2016Dec 31, 2016$3.16M+1185.3%
FY2014Jun 30, 2014$246.00K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ1 2026Jun 30, 2026$2.80M+8.4%
Q4 FY2024CQ4 2024Dec 31, 2024$1.96M-54.8%
Q3 FY2024CQ3 2024Sep 30, 2024$1.51M-72.2%
Q2 FY2024CQ2 2024Jun 30, 2024$1.47M-78.8%
Q1 FY2024CQ1 2024Mar 31, 2024$2.58M-66.4%
Q4 FY2023CQ4 2023Dec 31, 2023$4.32M-46.2%
Q3 FY2023CQ3 2023Sep 30, 2023$5.43M-34.2%
Q2 FY2023CQ2 2023Jun 30, 2023$6.92M-23.2%
Q1 FY2023CQ1 2023Mar 31, 2023$7.67M-21.8%
Q4 FY2022CQ4 2022Dec 31, 2022$8.04M-27.3%
Q3 FY2022CQ3 2022Sep 30, 2022$8.25M-29.2%
Q2 FY2022CQ2 2022Jun 30, 2022$9.01M-25.3%
Q1 FY2022CQ1 2022Mar 31, 2022$9.80M+4895.5%
Q4 FY2021CQ4 2021Dec 31, 2021$11.06M+1157.9%
Q3 FY2021CQ3 2021Sep 30, 2021$11.66M+1063.4%
Q2 FY2021CQ2 2021Jun 30, 2021$12.06M+915.4%
Q1 FY2021CQ1 2021Mar 31, 2021$196.14K-75.0%
Q4 FY2020CQ4 2020Dec 31, 2020$879.25K+4.4%
Q3 FY2020CQ3 2020Sep 30, 2020$1.00M+248.8%
Q2 FY2020CQ2 2020Jun 30, 2020$1.19M+239.6%
Q1 FY2020CQ1 2020Mar 31, 2020$785.85K+69.1%
Q4 FY2019CQ4 2019Dec 31, 2019$842.27K+20.9%
Q3 FY2019CQ3 2019Sep 30, 2019$287.29K-71.0%
Q2 FY2019CQ2 2019Jun 30, 2019$349.77K-68.0%
Q1 FY2019CQ1 2019Mar 31, 2019$464.78K-68.4%
Q4 FY2018CQ4 2018Dec 31, 2018$696.88K-60.9%
Q3 FY2018CQ3 2018Sep 30, 2018$990.45K-55.4%
Q2 FY2018CQ2 2018Jun 30, 2018$1.09M-55.5%
Q1 FY2018CQ1 2018Mar 31, 2018$1.47M-47.0%
Q4 FY2017CQ4 2017Dec 31, 2017$1.78M-43.7%
Q3 FY2017CQ3 2017Sep 30, 2017$2.22M-38.1%
Q2 FY2017CQ2 2017Jun 30, 2017$2.45M-35.2%
Q1 FY2017CQ1 2017Mar 31, 2017$2.77M-26.2%
Q4 FY2016CQ4 2016Dec 31, 2016$3.16M+1185.3%
Q3 FY2016CQ3 2016Sep 30, 2016$3.59M–
Q2 FY2016CQ2 2016Jun 30, 2016$3.79M–
Q1 FY2016CQ1 2016Mar 31, 2016$3.75M–
Q4 FY2014CQ2 2014Jun 30, 2014$246.00K–

More Protagenic Therapeutics, Inc.new figures

See a number that looks wrong?